Table 1

Sociodemographic and clinical characteristic of multidrug-resistant and extensively drug-resistant TB cases across all study sites and mortality rates (n=737)

TotalMortality
nN%Person-yearsDeathsRate; 95% CI
Demographic factors
Age group (years)
 15–2910973715294134.42 (2.57 to 7.62)
 30–3914873720451378.20 (5.94 to 11.31)
 40–49192737265326211.66 (9.09 to 14.96)
 50–59196737275767212.50 (9.92 to 15.75)
 ≥6092737122214319.46 (14.43 to 26.24)
Gender
 Male58173779157519512.38 (10.76 to 14.25)
 Female15673721499326.41 (4.53 to 9.06)
Living settings
 Urban49973768140514910.61 (9.04 to 12.46)
 Rural238737326707811.65 (9.33 to 14.54)
Social factors
Employment
 Unemployed48173665139417312.41 (10.69 to 14.4)
 Retired71736101823117.00 (11.96 to 24.17)
 Employed18473625495234.65 (3.09 to 6.99)
Homelessness
 Homeless5473771441711.79 (7.33 to 18.97)
 Have home68373793193021010.88 (9.5 to 12.46)
Substance abuse*
Smoking
 Yes43457076122915212.37 (10.55 to 14.5)
 No13657024363277.44 (5.1 to 10.85)
Alcohol abuse
 Yes42173158118217014.38 (12.37 to 16.71)
 No31073142868536.10 (4.66 to 7.99)
Recreational drugs
 Yes377195981111.23 (6.22 to 20.29)
 No68271995192820810.79 (9.42 to 12.36)
Co-morbidities†
HIV
 Negative5107376914631419.64 (8.17 to 11.37)
 Positive207373331030.51 (16.41 to 56.7)‡
 Not tested207737285797613.14 (10.49 to 16.45)
Condition other than HIV †
 Yes377375812227.10 (17.84 to 41.16)‡
 No70073795199320510.29 (8.97 to 11.8)
Disease characteristics
New or retreatment case
 New case336737467327910.79 (8.65 to 13.45)
 Retreatment case40173754134214811.03 (9.39 to 12.96)
Pulmonary or extrapulmonary
 Pulmonary only70573796201021210.55 (9.22 to 12.07)
 Both pulmonary and extrapulmonary327374641523.47 (14.15 to 38.94)‡
Drug resistance pattern§
 MDR39570556103111310.96 (9.12 to 13.18)
 MDR+FQres4370561491510.06 (6.07 to 16.69)
 MDR+INJres186705265105210.19 (7.77 to 13.37)
 XDR81705113073611.73 (8.46 to 16.26)
Presence of cavities
 Yes45673262127814911.66 (9.93 to 13.69)
 No27673238785779.81 (7.85 to 12.27)
Smear positivity at diagnosis
 Yes57373778380287.37 (5.09 to 10.67)
 No16473722337319.19 (6.46 to 13.06)
Unsuccessful treatment outcome in the past
 Yes216401548859210.40 (8.48 to 12.75)
 No185401464575612.26 (9.43 to 15.93)
  • *Alcohol excess and recreational drug use were determined by physicians and reported as stated in patients’ case histories according to nationally accepted breakdown categorisation.

  • †Including hepatitis B, hepatitis C, chronic liver condition, other immunocompromised conditions (including autoimmune disorders), cancer.

  • ‡Highest mortality rates >20.

  • §MDR, multidrug resistance, no additional resistance to FQs or second-line injectable agents; XDR, extensive drug resistance; INJres, resistance to second-line injectable agents; FQres, resistance to fluoroquinolones.